Combination aims to transform the genomics landscape and deliver a differentiated product offering into high growth clinical markets Brings together Omniome’s high accuracy short-read sequencing platform, with PacBio’s market leading, high accuracy long-read solutions Transaction supported by concurrent $300 million PIPE financing from premier life science investors MENLO PARK, Calif. and SAN DIEGO — Pacific […]

Collaboration to develop production-scale HiFi Sequencing platform expected to Include technology from Omniome, Inc. Combining both highly accurate long and short read sequencing technologies expected to provide deeper clinical insights and lower the overall cost of analysis MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, […]

TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the creation of a new business unit, HTG Therapeutics. HTG plans to use this new drug discovery business unit to leverage its capabilities and expand upon the utility of the HTG EdgeSeq […]

Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced the appointments of Brian Stolz as Chief People Officer, Diana King as Vice President of Customer Support, and Jordan Neysmith as Vice President of Engineering. The new leadership appointments follow the recent close of $276 million in Series C financing and support […]

Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers CARLSBAD, Calif. — Thermo Fisher Scientific today announced a new suite of Ion Torrent Oncomine immune repertoire assays designed to detect potentially malignant clones of T-cells and B-cells, which play a key role in the immune response system*. Using proprietary Ion AmpliSeq […]

Expanding initiative focused on next generation sequencing services tailored to research needs CORALVILLE, Iowa — Integrated DNA Technologies, Inc. (IDT), a leading comprehensive genomics research solutions provider, has added Predicine to the IDT Align Program. This move expands the program’s roster of preferred sequencing providers. The combination of IDT’s high quality and flexible next generation sequencing (NGS) […]

Celemics signs a supply agreement for BTSeq™ solution with Chinese Sanger sequencing service company – Celemics enters the Chinese DNA Sequencing market since its establishment – NGS-based BTSeq™ solution allows for highly accurate DNA sequencing with significantly reduced cost and time – The agreement scale is equivalent to 87% in celemics’ annual revenue Seoul, Korea: Celemics, […]

Seoul, South Korea – South Korea-based Sanigen has announced that it will become a regional distributor for Illumina, the world’s leading genome sequencing company. The partners will work together to bring Illumina’s NGS platform technology to the food safety and microbiology sectors in South Korea. Sanigen is a company specializing in food safety South Korea and serves the market […]

Cardea Bio, a Tech+Bio company that has integrated molecular biology with semiconductor electronics, today announced that Dawn Barry has joined the company’s Board of Directors. Dawn Barry is the President & co-founder of LunaPBC, Inc., which was named by the World Economic Forum as a Technology Pioneer in 2019. SAN DIEGO — Cardea technology taps […]

• Celemics enters the Chinese DNA Sequencing market since its establishment• NGS-based BTSeq™ solution allows for highly accurate DNA sequencing with significantly reduced cost and time • The agreement scale is equivalent to 87% in celemics’ annual reven Seoul, Korea – Celemics, Inc. (www.celemics.com), an NGS-based sequencing solution and bioinformatics company, Co-CEO Young-hoon Lee and […]